C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
CNBSF Equity

CNBSF

OTCMKTS · CNBSF

—
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
41/100 composite
Fundamentals40
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

CIN assigns Cansortium / Fluent a Neutral rating with a 40.8 composite score and 3/5 conviction. The regulatory pillar leads at 49, supported by an 80 enforcement subscore and a 50 jurisdiction posture, although a 25 cadence subscore limits the contribution. Fundamentals and market each contribute 40, but both reflect information gaps rather than demonstrated operating or trading strength. The fundamentals pillar carries an unknown condition because licensed fundamentals data are unavailable, while the market pillar lacks a current quote from institutional pricing feeds. Editorial contributes 30, the weakest pillar, with no newsroom or brief activity recorded in CIN newsroom coverage. The resulting profile sits firmly in the Neutral band: regulatory standing provides relative support, but absent financial, pricing, and editorial confirmation prevents a stronger rating.

Revenue growth and margin direction cannot be established from the available inputs. No revenue, gross margin, operating margin, EBITDA, net income, cash, or leverage figures are supplied through licensed fundamentals data, leaving the company’s financial condition unknown. Primary regulatory filings also provide no dated latest filing in the dataset, while filing-related event counts remain at zero across both the 90-day and 180-day windows. That absence drives the weak cadence subscore and reduces confidence in financial recency. At the same time, zero enforcement hits support the regulatory pillar’s strongest subscore. Institutional pricing feeds provide no quote, preventing assessment of momentum, valuation, liquidity, or market confirmation. CIN newsroom coverage contains no newsroom hits and no brief hits, matching the editorial pillar’s low contribution.

The clearest path to a higher composite runs through the regulatory pillar, already the strongest component of the framework. A current primary regulatory filing could lift cadence from its depressed level, establish an updated disclosure timeline, and supply the operating evidence currently missing from fundamentals. Such a filing could also clarify revenue growth, margins, and financial condition without relying on unsupported inference. With jurisdiction posture near the midpoint and enforcement history providing the strongest support, improved filing recency represents the most direct catalyst for conviction. The single most important signal to watch is the appearance of a newly dated primary regulatory filing.

Scored: 2026-10-16Valid through: 2026-11-30Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for CNBSF (CNBSF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CNBSF (CNBSF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CNBSF are maintained by Cannabis Investor News and refreshed throughout the trading day.